About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,811 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,811 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2401-2420 of 10,811 trials

CompletedStudy of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast CancerObjective: To determine the Overall Response Rate (ORR) to Imprime PGG + pembrolizumab in subjects with advanced melanoma or metastatic TNBC Safety: To characterize the safety of…NCT02981303·Avondale, Arizona and 9 others CompletedA Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary IncontinenceThe purpose of this study is to obtain surgical technique data for use in physician education and training and to collect early clinical outcomes data for future publication.NCT00904969·Los Angeles, California and 10 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedSafety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic HypogonadismThe purpose of this study is to evaluate the safety and efficacy of BGS649 in male obese subjects with hypogonadotropic hypogonadism.NCT02730169·Birmingham, Alabama and 62 others

CompletedDepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid TumorThe purpose of this study is to find out how well an experimental drug called DepoCyt works for neoplastic meningitis (cancer that has spread to the tissues around the brain and…NCT00029523·Phoenix, Arizona and 22 others

Terminated(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLCThis is a Phase 1/2, open-label, first-in-human (FIH) study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and anticancer activity of…NCT04862780·La Jolla, California and 25 others

Active not recruitingA Study to Evaluate XEN1101 as Adjunctive Therapy in Focal EpilepsyThe XEN1101 Phase 2 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of increasing doses of…NCT03796962·Birmingham, Alabama and 94 others

CompletedSafety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior ChemotherapyThe purpose of this study is to determine if the study drug pertuzumab is effective in treating patients with advanced lung cancer that has recurred following prior chemotherapy.NCT00063154·Scottsdale, Arizona and 7 others

CompletedA Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell CarcinomaThis multicenter, randomized, open-label study will evaluate the efficacy, safety and tolerability of atezolizumab as monotherapy or in combination with bevacizumab versus…NCT01984242·Scottsdale, Arizona and 44 others

CompletedA Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in ChildrenThe primary objective of this study is to demonstrate the immunologic noninferiority of Q/LAIV to FluMist in children 2 to 17 years of age.NCT01091246·Birmingham, Alabama and 109 others

CompletedRandomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent RestenosisThe objective of this study is to evaluate the safety and effectiveness of the TAXUS Express2 Paclitaxel-Eluting Coronary Stent System as compared to brachytherapy in patients…NCT00287573·Birmingham, Alabama and 41 others

CompletedReal-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)The primary objective of the study is to evaluate relapse activity, as measured by the proportion of participants relapsed at 12 months, in participants with relapsing-remitting…NCT02159573·Birmingham, Alabama and 42 others

CompletedItacitinib for Low Risk GVHDGraft-versus-host disease (GVHD) is treated with high doses of systemic steroids which can lead to serious complications.NCT03846479·Duarte, California and 13 others

CompletedModel 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval StudyThe Medtronic CapSure Epi Lead Post-approval Study will assess long-term safety of the 4968 lead. This study is part of the Medtronic System Longevity Study.NCT01076361·Anchorage, Alaska and 105 others

RecruitingPREcision MEDicine In Achalasia (PREMEDIA)The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain…NCT07293650·Scottsdale, Arizona and 15 others

CompletedChest Wall Repair of Rib Fractures After TraumaThis is a prospective, observational trial of 50 patients who have multiple, severe rib fractures following trauma.NCT00926991·Nashville, Tennessee

RecruitingPhase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)This is a first-in-human, open-label, dose escalation and expansion study of UCART22 administered intravenously to patients with relapsed or refractory B-cell acute Lymphoblastic…NCT04150497·Los Angeles, California and 18 others

CompletedStudy of XL281 in Adults With Solid TumorsThe purpose of this study is to determine the safest dose of the multiple Raf kinase inhibitor (including c-Raf, B-Raf, and the activated mutant B-RafV600E) XL281, how often it…NCT00451880·Scottsdale, Arizona and 5 others

CompletedNovel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)The purpose of this research study is to assess the response rate of the investigational drug BMS-247550 (Ixabepilone) in women with metastatic breast cancer who are refractory to…NCT00080262·La Verne, California and 44 others

CompletedA Study Of Panobinostat In Children With Refractory Hematologic MalignanciesThis study is for patients with relapsed or refractory Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Hodgkin's Disease (HD) or Non-Hodgkin's Lymphoma (NHL).NCT01321346·Los Angeles, California and 19 others

CompletedSafety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected AdultsThe purpose of this study is to determine the safety of and immune response to an experimental HIV vaccine in HIV uninfected individuals.NCT00119873·San Francisco, California and 2 others

PreviousPage 121 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville